2/4
05:05 pm
pbyi
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
1/22
05:00 am
pbyi
New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
Medium
Report
New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
1/13
01:56 pm
pbyi
Investing in Puma Biotechnology (NASDAQ:PBYI) a year ago would have delivered you a 103% gain [Yahoo! Finance]
Low
Report
Investing in Puma Biotechnology (NASDAQ:PBYI) a year ago would have delivered you a 103% gain [Yahoo! Finance]
1/7
05:15 pm
pbyi
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
12/31
02:28 pm
pbyi
Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag? [Yahoo! Finance]
Low
Report
Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag? [Yahoo! Finance]
12/22
04:23 pm
pbyi
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) [Yahoo! Finance]
Low
Report
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) [Yahoo! Finance]
12/22
04:10 pm
pbyi
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
Low
Report
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
12/21
08:55 am
pbyi
If EPS Growth Is Important To You, Puma Biotechnology (NASDAQ:PBYI) Presents An Opportunity [Yahoo! Finance]
Low
Report
If EPS Growth Is Important To You, Puma Biotechnology (NASDAQ:PBYI) Presents An Opportunity [Yahoo! Finance]
12/2
05:15 pm
pbyi
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
11/30
08:41 am
pbyi
With 60% ownership of the shares, Puma Biotechnology, Inc. (NASDAQ:PBYI) is heavily dominated by institutional owners [Yahoo! Finance]
Low
Report
With 60% ownership of the shares, Puma Biotechnology, Inc. (NASDAQ:PBYI) is heavily dominated by institutional owners [Yahoo! Finance]